Αρχειοθήκη ιστολογίου

Δευτέρα 24 Ιουλίου 2017

SillaJen and Lee's Pharma to initiate Phase III liver cancer trial of Pexa-Vec

South Korean biotherapeutics firm SillaJen and Hong Kong-based biopharmaceutical company Lee's Pharmaceutical Holdings have secured approval from the China Food and Drug Administration (CFDA) for a Phase III clinical trial (PHOCUS) of Pexa-Vec in pat … (Source: Drug Development Technology)

from ! Medicine by Alexandros G. Sfakianakis via alwin on Inoreader http://ift.tt/2vC3iyH
via IFTTT

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,00306932607174,alsfakia@gmail.com,

Αναζήτηση αυτού του ιστολογίου

! # Ola via Alexandros G.Sfakianakis on Inoreader